We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Hovnanian Enterprises
HOV
$807M
| $2.12M | 0.01% |
13,528
-14,732
| -52% | -$2.27M |
|
1402
Arista Networks
ANET
$238B
| $2.12M | 0.01% |
29,200
| – | – |
|
1403
Workiva
WK
$3.54B
| $2.11M | 0.01% |
24,900
-28,539
| -53% | -$2.57M |
|
|
REFI
1404
Chicago Atlantic Real Estate Finance
REFI
$261M
| $2.11M | 0.01% |
133,807
+2,654
| +2% | +$42.5K |
|
1405
CEVA Inc
CEVA
$1.08B
| $2.11M | ﹤0.01% |
92,801
+32,662
| +54% | +$714K |
|
|
TE
1406
T1 Energy
TE
$1.63B
| $2.1M | ﹤0.01% |
1,252,767
-882,374
| -41% | -$1.4M |
|
1407
Cactus
WHD
$5.44B
| $2.1M | ﹤0.01% |
42,008
-18,138
| -30% | -$803K |
|
1408
Morningstar
MORN
$7.53B
| $2.1M | ﹤0.01% |
6,800
-300
| -4% | -$86.4K |
|
|
SNV
1409
DELISTED
Synovus
SNV
| $2.09M | ﹤0.01% |
52,235
+713
| +1% | +$26.8K |
|
1410
Luxfer Holdings
LXFR
$458M
| $2.09M | ﹤0.01% |
201,638
-98,573
| -33% | -$882K |
|
1411
Willis Towers Watson
WTW
$32B
| $2.09M | ﹤0.01% |
+7,590
| New | +$2M |
|
1412
Mueller Industries
MLI
$15.2B
| $2.08M | ﹤0.01% |
77,200
-147,548
| -66% | -$3.65M |
|
1413
Alpha and Omega Semiconductor
AOSL
$1.08B
| $2.07M | ﹤0.01% |
94,054
+39,952
| +74% | +$966K |
|
|
CLCO
1414
DELISTED
Cool Company
CLCO
| $2.07M | ﹤0.01% |
186,312
-26,888
| -13% | -$312K |
|
1415
Angi Inc
ANGI
$196M
| $2.07M | ﹤0.01% |
78,867
+1,749
| +2% | +$44.6K |
|
1416
Banc of California
BANC
$2.97B
| $2.07M | ﹤0.01% |
135,817
-683,241
| -83% | -$9.5M |
|
1417
Center Bancorp
CNOB
$1.78B
| $2.07M | ﹤0.01% |
105,898
+71,994
| +212% | +$1.51M |
|
1418
Moderna
MRNA
$23.6B
| $2.06M | ﹤0.01% |
19,377
| – | – |
|
1419
iShares Core S&P Small-Cap ETF
IJR
$112B
| $2.06M | ﹤0.01% |
18,679
+11,979
| +179% | +$1.27M |
|
1420
Gibraltar Industries
ROCK
$1.49B
| $2.06M | ﹤0.01% |
25,607
-37,850
| -60% | -$3.02M |
|
|
BBBY
1421
Bed Bath & Beyond
BBBY
$442M
| $2.06M | ﹤0.01% |
63,140
-11,550
| -15% | -$297K |
|
1422
Liberty Latin America Class C
LILAK
$1.64B
| $2.05M | ﹤0.01% |
323,017
+242,387
| +301% | +$1.5M |
|
1423
PUT
PagerDuty
PD
$902M
| $2.05M | ﹤0.01% |
90,400
+31,600
| +54% | +$750K |
|
|
MOR
1424
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $2.05M | ﹤0.01% |
112,957
-72,970
| -39% | -$1.08M |
|
1425
Palo Alto Networks
PANW
$297B
| $2.05M | ﹤0.01% |
14,418
+18
| +0.1% | +$2.84K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.